I am from Dallas, Texas, and I received my B.A. in Molecular and Cellular Biology from Vanderbilt University in Nashville, TN. After graduation, I worked at the Vaccine Research Center at the NIH in Dr. John Mascola's group studying the co-evolution of antibody and virus responses in the context of HIV. Then, I returned to Nashville to pursue my graduate studies in Dr. Ivelin Georgiev's laboratory as part of the Vanderbilt Vaccine Center. While there, I worked on the development of a high throughput antibody discovery technology called LIBRA-seq (Linking B cell receptor to antigen specificity through sequencing), and I applied LIBRA-seq to discover and characterize novel neutralizing antibodies to various pathogens, including HIV, influenza and SARS-CoV-2. I joined the Diamond laboratory as a postdoctoral researcher and am interested in the discovery, characterization, and design of antibodies and nanobodies to neurodegenerative diseases.